S. Vermaak

发表

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial

P. Kaleebu, H. McShane, R. Galiwango, 2017, PLoS neglected tropical diseases.

Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

H. McShane, S. Mboup, P. Sow, 2013, PloS one.

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults

P. Moss, H. McShane, A. Lawrie, 2016, Vaccine.

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults

P. Moss, B. Landry, H. McShane, 2015, PloS one.

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial

H. McShane, A. Lawrie, S. Harris, 2019, PLoS medicine.

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults

F. Gleeson, P. Moss, H. McShane, 2021, Vaccines.

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults

P. Moss, H. McShane, M. O’Shea, 2019, Vaccine.

The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses

M. Tameris, M. Hatherill, T. Scriba, 2014, PloS one.

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A

P. Kaleebu, H. McShane, A. Lawrie, 2018, Wellcome open research.

VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy

P. Kaye, H. McShane, R. Reljic, 2018, F1000Research.

Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity

P. Moss, H. McShane, S. Harris, 2015, The Journal of infectious diseases.

University of Birmingham Optimization of a human Bacille Calmette-Guérin challenge model

H. McShane, S. Harris, L. Stockdale, 2016 .

The South African society of psychiatrists (SASOP) and SASOP State Employed Special Interest Group (SESIG) position statements on psychiatric care in the public sector

Dan J Stein, D. Stein, J. Burns, 2012 .